Small Molecules
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
503
NCT00984802
Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2010
Completion: Apr 30, 2011
NCT02103959
Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
Start: Jun 30, 2014
Completion: Dec 31, 2015
Loading map...